Project Number AMP AD-19-622228 Agency/Funding Organization Alzheimer's Association Funding Year 2019 View Full Project Details for A4 Trial Data and Sample Preparation Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 8. Late-stage Clinical Drug Development (Phase II/III and III Clinical Trials) a. Amyloid beta Researcher and Organization Principal Investigator Sperling Reisa Principal Investigator First Name Reisa Principal Investigator Last Name Sperling Awardee Organization Brigham and Women's Hospital, Inc. Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement SG: SG FY Overall Cost $121,000 Funding Organization Agency/Funding Organization Alzheimer's Association Funding Organization Country United States Program Official Murtishaw, Andrew asmurtishaw@alz.org
